Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Manuscript
  • Published:

Acute Promyelocytic Leukemia

The incidence of acute promyelocytic leukemia appears constant over most of a human lifespan, implying only one rate limiting mutation

Leukemia volume 14, pages 722–726 (2000)Cite this article

Abstract

It is believed that most malignancies become more common with increasing age due to the requirement for several mutations to accumulate and subsequently interact. The age specific incidence of acute promyelocytic leukemia (APL) was investigated using population-based data from 77 million subject years of observation, yielding 149 consecutive cases. The incidence appears approximately constant with respect to age, an observation not previously reported with any other malignancy. These findings are most easily explained by there being only one rate limiting genetic event required to initiate the disease, although other, non-rate limiting mutations may also be necessary for disease development. It is also argued that this mutation is probably restricted to cells committed to differentiation, which may explain why APL is curable by chemotherapy.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2

Similar content being viewed by others

References

  1. Vogelstein B, Kinzler KW . The multistep nature of cancer Trends Genet 1993 9: 138–141

    Article  CAS  PubMed  Google Scholar 

  2. Hahn WC, Counter CM, Lundberg AS, Beijersbergen RL, Brooks MW, Weinberg RA . Creation of human tumour cells with defined genetic elements Nature 1999 400: 464–468

    Article  CAS  PubMed  Google Scholar 

  3. Hethcote HW, Knudson AG . Model for the incidence of embryonal cancers: application to retinoblastoma Proc Natl Acad Sci USA 1978 75: 2453–2457

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Varmus H, Weinberg RA . Genes and the Biology of Cancer Scientific American Library; WH Freeman and Co: New York 1993

    Google Scholar 

  5. Stein WD . Analysis of cancer incidence data on the basis of multistage and clonal growth models Adv Cancer Res 1991 56: 161–213

    Article  CAS  PubMed  Google Scholar 

  6. Loeb LA . Mutator phenotype may be required for multistage carcinogenesis Cancer Res 1991 51: 3075–3079

    CAS  PubMed  Google Scholar 

  7. Fenaux P, Chomienne C, Degos L, Grimwade D . Acute promyelocytic leukemia: biology and treatment Semin Oncol 1997 24: 92–102

    CAS  PubMed  Google Scholar 

  8. Bennett B, Booth NA, Croll A, Dawson AA . The bleeding disorder in acute promyelocytic leukemia: fibrinolysis due to u-PA rather than defibrination Br J Haematol 1989 71: 511–517

    Article  CAS  PubMed  Google Scholar 

  9. de Thé H, Chomienne C, Lanotte M, Degos L, Dejean A . The t(15;17) translocation of acute promyelocytic leukemia fuses the retinoic acid receptor α gene to a novel transcribed locus Nature 1990 347: 558–561

    Article  PubMed  Google Scholar 

  10. Fenaux P, Degos L . Differentiation therapy for acute promyelocytic leukemia New Engl J Med 1997 337: 1076–1077

    Article  CAS  PubMed  Google Scholar 

  11. Peto R, Parish SE, Gray RG . There is no such thing as ageing, and cancer is not related to it. In: Likhachev A, Anisimov V, Montesano R (eds) Age-related Factors in Carcinogenesis, International Agency for Research on Cancer Scientific Publications: Lyon, No 58 1986 pp 43–53

    Google Scholar 

  12. Akiyama M, Kyoizumi S, Hirai Y, Kusonoki Y, Iwamoto KS, Makamura N . Mutation frequency in human blood cells increases with age Mutat Res 1995 338: 141–149

    Article  CAS  PubMed  Google Scholar 

  13. de Haan G, Van Zant G . Dynamic changes in mouse hematopoietic stem cell numbers during aging Blood 1999 93: 3294–3301

    CAS  PubMed  Google Scholar 

  14. Taylor P, Jackson G, Vickers M, Ross J, Gorst D, Clough V, Brown M, Poctor S . A population based study on the effect of age, WCC, cytogenetics and ATRA on outcome in acute promyelocytic leukemia Blood 1997 90: 234b

    Google Scholar 

  15. Ramsey MJ, Moore DH, Briner JF, Lee DA, Olsen LA, Senft JR, Tucker JD . The effects of age and lifestyle factors on the accumulation of cytogenetic damage as measured by chromosome painting Mutat Res 1995 338: 95–106

    Article  CAS  PubMed  Google Scholar 

  16. Green MHL, O'Neill JP, Cole J . Suggestions concerning the relationship between mutant frequency and mutation rate at the hrpt locus in human peripheral T-lymphocytes Mutat Res 1995 334: 323–339

    Article  CAS  PubMed  Google Scholar 

  17. Westervelt P, Ley TJ . Seed versus soil: the importance of the target cell for transgenic models of human leukemias Blood 1999 93: 2143–2148

    CAS  PubMed  Google Scholar 

  18. David G, Terris B, Marchio A, Lavau C, Dejean A . The acute promyelocytic leukemia PML-RAR alpha protein induces hepatic preneoplastic and neoplastic lesions in transgenic mice Oncogene 1997 14: 1547–1554

    Article  CAS  PubMed  Google Scholar 

  19. Early E, Moores M, Kakizuka A, Nason-Burchenal K, Martin P, Evans R, Dmitrowsky X . Transgenic expression of PML-RARα impairs myelopoiesis Proc Natl Acad Sci USA 1996 93: 7900–7904

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Grisolano JL, Wesselschmidt RL, Pelicci PG, Ley TJ . Altered myeloid development and acute leukemia in transgenic mice expression PML-RAR alpha under control of cathepsin G regulatory sequences Blood 1997 89: 376–387

    CAS  PubMed  Google Scholar 

  21. He LZ, Tribioli C, Rivi R, Peruzzi D, Pelicci PG, Soares V, Cattoretti G, Pandolfi PP . Acute leukemia with promyelocytic features in PML/RAR alpha transgenic mice Proc Natl Acad Sci USA 1997 94: 5302–5307

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Shao W, Benedetti L, Lamph WW, Nervi C, Miller WH . A retinoid-resistant acute promyelocytic leukemia subclone expresses a dominant negative PML-RAR alpha mutation Blood 1997 89: 4282–4289

    CAS  PubMed  Google Scholar 

  23. Brown D, Kogan S, Lagasse E, Weissman I, Alcalay M, Pelicci PG, Atwater S, Bishop JM . A PML/RARα transgene initiates murine acute promyelocytic leukemia Proc Natl Acad Sci USA 1997 94: 2551–2556

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Melnick A, Licht JD . Deconstructing a disease: RARα, its fusion partners, and their roles in the pathogenesis of acute promyelocytic leukemia Blood 1999 93: 3167–3215

    CAS  PubMed  Google Scholar 

  25. Heinzel T, Lavinsky R, Mullen T, Soderstrom M, Laherty C, Torchia J, Yang W-M, Brard G, Ngo S, Davie J, Seto E, Eisenman R, Rose D, Glass C, Rosenfeld M . A complex containing N-CoR, mSin3 and histone deacetylase mediates transcriptional repression Nature 1997 387: 43–48

    Article  CAS  PubMed  Google Scholar 

  26. Onodera M, Kunisada T, Nishikawa S, Sakiyama Y, Matsumoto S, Nishikawa S . Overexpression of retinoic acid alpha suppresses myeloid cell differentiation at the promyelocytic stage Oncogene 1995 11: 1291–1299

    CAS  PubMed  Google Scholar 

  27. Grignani F, Ferrucci PF, Testa U, Talamo G, Fagioli M, Alcalay M, Mencarelli A, Grignani F, Peschle C, Nicoletti I, Pelicci PG . The acute promyelocytic leukemia-specific PML/RAR alpha fusion protein inhibits differentiation and promotes survival of myeloid precursor cells Cell 1993 74: 423–431

    Article  CAS  PubMed  Google Scholar 

  28. Perez A, Kastner P, Sethi S, Lutz Y, Reibel C, Chambon P . PMLRAR homodimers: distinct DNA binding properties and heteromeric interactions with RXR EMBO J 1993 12: 3171–3182

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  29. Jansen JH, Mahfoudi A, Rambaud S, Lavau C, Wahli W, Dejean A . Multimeric complexes of the PML-retinoic acid receptor alpha fusion protein in acute promyelocytic leukemia cells and interference with retinoid and peroxisome-proliferator signaling pathways Proc Natl Acad Sci USA 1995 92: 7401–7405

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  30. Lamorte VJ, Dyck JA, Ochs RL, Evans RM . Localisation of nascent RNA and CREB binding protein with the PML-containing nuclear body Proc Natl Acad Sci USA 1998 95: 4991–4996

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  31. Vallian S, Gaken JA, Gingold EB, Kouzarides T, Chang KS, Farzaneh F . Modulation of Fos-mediated AP1 transcription by the promyelocytic leukemia protein Oncogene 1998 16: 2843–2853

    Article  CAS  PubMed  Google Scholar 

  32. Lafage-Pochitaloff M, Alcalay M, Brunel V, Longo L, Sainty D, Simonetti J, Birg F, Pelicci PG . Acute promyelocytic leukemia cases with nonreciprocal PML/RARα or RARα/PML fusion genes Blood 1995 85: 1169–1174

    CAS  PubMed  Google Scholar 

  33. Mozziconacci M-J, Liberatore C, Brunel V, Grignani F, Arnoulet C, Ferrucci PF, Fernandez F, Sainty D, Pelicci PG, Birg F, Lafage-Pochitaloff M . In vitro response to all trans retinoic acid of acute promyelocytic leukemias with nonreciprocal PML/RARA or RARA/PML fusion genes Gene Chromosomes Cancer 1998 22: 241–250

    Article  CAS  Google Scholar 

  34. Turhan AG, Lemoine FM, Debert C, Bonnet ML, Baillon C, Picard F, Macintyre EA, Varet B . Highly purified primitive hematopoietic stem cells are PML-RARA negative and generate non-clonal progenitors in acute promyelocytic leukemia Blood 1995 85: 2154–2161

    CAS  PubMed  Google Scholar 

  35. Knuutila S, Majander P, Ruutu T . 8;21 and 15;17 translocations: abnormalities in a single cell lineage in acute myeloid leukemia Acta Haematol 1994 92: 88–90

    Article  CAS  PubMed  Google Scholar 

  36. Haferlach T, Loffler H, Nickenig C, Ramm-Petersen L, Meeder M, Schoch R, Schlegelberger B, Schnittger S, Schoch C, Hiddemann W . Cell lineage specific involvement in acute promyelocytic leukaemia (APL) using a combination of May–Grunwald-Giemsa staining and fluorescence in situ hybridisation techniques for the detection of the translocation t(15;17)(q22;q12) Br J Haematol 1998 103: 93–99

    Article  CAS  PubMed  Google Scholar 

  37. Bonnet D, Dick JE . Human acute myeloid leukaemia is organised as a hierarchy that originates from a primitive hematopoietic cell Nature Med 1997 3: 730–737

    Article  CAS  PubMed  Google Scholar 

  38. Vickers M, Brown GC, Cologne JB, Kyoizumi S . Modelling haemopoietic stem cell division by analysis of mutant red cells Br J Haematol(in press)

Download references

Acknowledgements

We wish to thank the many hematologists who contributed patients to this survey, in particular, Drs JRY Ross, V Clough and D Gorst who maintain the Oxford, Merseyside and North-Western Registers.

Author information

Authors and Affiliations

  1. Department of Haematology, Medicine and Therapeutics, Aberdeen, UK

    M Vickers

  2. Department of Haematology, Royal Victoria Infirmary, Newcastle, UK

    G Jackson & P Taylor

Authors
  1. M Vickers
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. G Jackson
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. P Taylor
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Vickers, M., Jackson, G. & Taylor, P. The incidence of acute promyelocytic leukemia appears constant over most of a human lifespan, implying only one rate limiting mutation. Leukemia 14, 722–726 (2000). https://doi.org/10.1038/sj.leu.2401722

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.leu.2401722

Keywords

This article is cited by

Search

Advanced search

Quick links